Department of Immunology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, 71348-45794, Iran.
Infection and Immunity Program and Department of Biochemistry and Molecular Biology, Biomedicine Discovery Institute, Monash University, Clayton, VIC, Australia.
BMC Immunol. 2024 Jun 28;25(1):38. doi: 10.1186/s12865-024-00631-1.
Variations in the innate and adaptive immune response systems are linked to variations in the severity of COVID-19. Natural killer cell (NK) function is regulated by sophisticated receptor system including Killer-cell immunoglobulin-like receptor (KIR) family. We aimed to investigate the impact of possessing certain KIR genes and genotypes on COVID19 severity in Iranians. KIR genotyping was performed on 394 age/sex matched Iranians with no underlying conditions who developed mild and severe COVID- 19. The presence and/or absence of 11 KIR genes were determined using the PCR with sequence specific primers (PCR-SSP).
Patients with mild symptoms had higher frequency ofKIR2DS1 (p = 0.004) and KIR2DS2 (p = 0.017) genes compared to those with severe disease. While KIR3DL3 and deleted variant of KIR2DS4 occurred more frequently in patients who developed a severe form of the disease. In this study, a significant increase of and B haplotype was observed in the Mild group compared to the Severe group (respectively, p = 0.002 and p = 0.02). Also, the prevalence of haplotype A was significantly higher in the Severe group than in the Mild group (p = 0.02).
These results suggest that the KIR2DS1, KIR2DS, and B haplotype maybe have a protective effect against COVID-19 severity. The results also suggest the inhibitory gene KIR2DL3 and haplotype A are risk factors for the severity of COVID-19.
先天和适应性免疫反应系统的变异与 COVID-19 的严重程度有关。自然杀伤细胞(NK)的功能受复杂的受体系统调节,包括杀伤细胞免疫球蛋白样受体(KIR)家族。我们旨在研究在伊朗人中,拥有某些 KIR 基因和基因型对 COVID19 严重程度的影响。对 394 名无潜在疾病且患有轻度和重度 COVID-19 的伊朗人进行了 KIR 基因分型。使用聚合酶链反应与序列特异性引物(PCR-SSP)确定 11 种 KIR 基因的存在和/或缺失。
与患有严重疾病的患者相比,症状较轻的患者具有更高频率的 KIR2DS1(p=0.004)和 KIR2DS2(p=0.017)基因。而 KIR3DL3 和 KIR2DS4 的缺失变体在发生严重疾病的患者中更为常见。在这项研究中,与严重组相比,轻度组中观察到显著增加的和 B 单倍型(分别为 p=0.002 和 p=0.02)。此外,严重组中 A 单倍型的患病率明显高于轻度组(p=0.02)。
这些结果表明,KIR2DS1、KIR2DS 和 B 单倍型可能对 COVID-19 的严重程度具有保护作用。结果还表明,抑制性基因 KIR2DL3 和单倍型 A 是 COVID-19 严重程度的危险因素。